Opioid Analgesics Suppress Male Gonadal Function, but Opioid Use in Men and Women Does Not Correlate with Symptoms of Sexual Dysfunction
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Opioid analgesia impairs gonadal function in men and women, but the correlation with symptoms and hormonal measurements of hypogonadism is not well established. OBJECTIVE: To determine the frequency of impaired gonadal function in men and women using opioids for chronic pain, and to determine the correlation of symptoms with hormonal measurements of gonadal function. METHODS: A prospective study of patients attending a multidisciplinary pain clinic was conducted. A total of 65 women (47 opioid users and 18 nonopioid analgesic controls) and 32 men (26 opioid users and six controls) were enrolled. Histories of sexual dysfunction and hormonal testing (men: total testosterone [TT], free testosterone [FT], prolactin and luteinizing hormone; women: FT, TT, prolactin, dehydroepiandrosterone sulphate, sex hormone‐binding globulin, progesterone, luteinizing hormone and follicle‐stimulating hormone, and estradiol) were obtained. RESULTS: In men, a low FT level was more common in opioid users (20/26; P=0.04). In men with abnormal hormone levels, there was no difference in the frequency of sexual dysfunction compared with men with normal hormone levels, and no difference in the frequency of opioid versus nonopioid use. In women, opioid users had lower FT levels (P=0.02). Low dehydroepiandrosterone sulphate was more frequent in women on opioids (P=0.03) in the menopausal group only (P=0.046). Premenopausal women taking opioids more frequently had a low TT level (P=0.03). The frequency of female sexual dysfunction was the same in opioid users (32/47) and controls (13/18; P=0.75), and also did not relate to any hormone abnormality. DISCUSSION: Men taking opioids had lower FT and higher prolactin levels, and women taking opioids had lower FT levels. Frequency of sexual dysfunction did not correlate with hormone levels in either men or women taking opioids. CONCLUSION: Opioids frequently cause low FT levels in men, but there is no relationship between abnormal hormone levels and symptoms of sexual dysfunction. Therefore, all men should be screened for low FT levels. Women on opioids had lower FT levels, but this did not correlate with sexual dysfunction symptoms. Therefore, measurements of FT or other hormones were not considered to be useful in women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, hyperprolactinemia has not been confirmed in other studies involving noncancer pain patients on intrathecal or oral opioids (74, 136, 148), although in one of them, PRL was higher (but still within normal range) in men in the opioidtreated group, as compared with the controls (148).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564 · cited 2×
“Human and animal data indicate that opioids suppress luteinizing hormone-releasing hormone and gonadotropin secretion, leading to decreased testosterone levels and abnormal menstrual function (6-8).”
BackgroundTrends in Medical Use and Abuse of Opioid Analgesics
Joranson, D. E. (2000) · JAMA · doi:10.1001/jama.283.13.1710 · Cited by 504
Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial
Buster, J. E., Kingsberg, S. A., Aguirre, O., Brown, C., Breaux, J. G., Buch, A., Rodenberg, C. A., Wekselman, K., & Casson, P. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000158103.27672.0d · Cited by 433
Hypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401
Daniell, H. W. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.08.005 · Cited by 263 · cited 2×
“Although most studies demonstrate suppression of testosterone in men (4,11,12), sexual dysfunction in men and women has been inconsistently studied (11,13,14).”
BackgroundResultDaniell, H. (2006) · Journal of Pain · doi:10.1016/j.jpain.2006.04.011 · Cited by 144
Decreased serum testosterone concentration in male heroin and methadone addicts
Azizi, F., Vagenakis, A. G., Longcope, C., Ingbar, S. H., & Braverman, L. E. (1973) · Steroids · doi:10.1016/0039-128x(73)90002-0 · Cited by 130
Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women
Fraser, L.-A., Morrison, D., Morley-Forster, P., Paul, T., Tokmakejian, S., Larry Nicholson, R., Bureau, Y., Friedman, T., & Uum, S. H. M. V. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1076715 · Cited by 112 · cited 1×
“Pain Res Manage Vol 16 No 5 September/October 2011 312 fatigue, hot flashes, mild anemia, osteoporosis and sarcopenia in men (10), and amenorrhea, oligomenorrhea, sexual dysfunction, fatigue, depression and osteoporosis in women.”
BackgroundHypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy
Rajagopal, A., Vassilopoulou‐Sellin, R., Palmer, J. L., Kaur, G., & Bruera, E. D. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(03)00331-2 · Cited by 95
Opioid-induced suppression of rat testicular function.
Adams, M. L., Sewing, B., Forman, J. B., Meyer, E. R., & Cicero, T. J. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38343-6 · Cited by 87
Cited by
Opioids and their endocrine effects: a systematic review and meta-analysis
de Vries, F., Bruin, M., Lobatto, D. J., Dekkers, O. M., Schoones, J. W., van Furth, W. R., Pereira, A. M., Karavitaki, N., Biermasz, N. R., & Zamanipoor Najafabadi, A. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz022 · Cited by 139
Yeap, B. B., Grossmann, M., McLachlan, R. I., Handelsman, D. J., Wittert, G. A., Conway, A. J., Stuckey, B. G., Lording, D. W., Allan, C. A., Zajac, J. D., et al. (2016) · Medical Journal of Australia · doi:10.5694/mja16.00393 · Cited by 135
Sexual Dysfunction in Patients with Alcohol and Opioid Dependence
Grover, S., Mattoo, S. K., Pendharkar, S. S., & Kandappan, V. (2014) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.140699 · Cited by 140
“[79] A major limitation of these data has been the lack of standard instruments to assess SD; only four recent studies using International Index of Erectile Function (IIEF), of which two used full form of IIEF to assess SD.”
BackgroundInfluentialMECHANISMS OF ENDOCRINOLOGY: endocrinology of opioids
Fountas, A., Chai, S. T., Kourkouti, C., & Karavitaki, N. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0270 · Cited by 60
Tramadol Abuse and Sexual Function
Abdel‐Hamid, I. A., Andersson, K., Waldinger, M. D., & Anis, T. H. (2016) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2015.10.014 · Cited by 57
Sexual Dysfunction in Men Seeking Treatment for Opioid Dependence: A Study from India
Kandappan, V., Mattoo, S. K., & Grover, S. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12588 · Cited by 42
Pain Medications and Male Reproduction
Drobnis, E. Z., & Nangia, A. K. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-69535-8_6 · Cited by 42
Baykara, S., & Alban, K. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.153 · Cited by 38
Zhao, S., Deng, T., Luo, L., Wang, J., Li, E., Liu, L., Li, F., Luo, J., & Zhao, Z. (2017) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.08.010 · Cited by 38
Opioid‐induced hypogonadism: Pathophysiology, clinical and therapeutics review
Antony, T., Alzaharani, S. Y., & El-Ghaiesh, S. H. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13246 · Cited by 40
Opioids and the Hypothalamic-Pituitary-Gonadal (HPG) Axis
Wehbeh, L., & Dobs, A. S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa417 · Cited by 39
Opioids and pituitary function: expert opinion
Gadelha, M. R., Karavitaki, N., Fudin, J., Bettinger, J. J., Raff, H., & Ben-Shlomo, A. (2022) · Pituitary · doi:10.1007/s11102-021-01202-y · Cited by 27
Wersocki, E., Bedson, J., Chen, Y., LeResche, L., & Dunn, K. M. (2017) · Pain · doi:10.1097/j.pain.0000000000000691 · Cited by 21
“Enough power to show statistical significance Setting: pain clinic Negatives: small numbers, 3 women receiving opioids on HRT, 0 in control group Duration of treatment: at least 1 y Sample size: Case N 5 16, controls N 5 6 Opioid: methadone, morphine, oxycodone Age: 48 y (32-63), split into women ,50 but no average ag…”
BackgroundInfluentialLin, T., Ger, L.-P., Pergolizzi, J. V., Raffa, R. B., Wang, J.-O., & Ho, S.-T. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.10.015 · Cited by 19
“Both men and women taking opioids have lower free testosterone levels,(26,27) but these levels cannot be correlated to the frequency of sexual dysfunction.(28) Adequate serum testosterone levels have an appreciable role in both males and females for libido and sexuality, cellular growth, maintenance of muscle mass and…”
BackgroundExogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Association between opioid use disorder and fractures: a population‐based study
Hsu, W., Lin, C., & Kao, C. (2019) · Addiction · doi:10.1111/add.14732 · Cited by 13
Long‐term opioid treatment and endocrine measures in chronic non‐cancer pain patients
Diasso, P. D. K., Abou‐Kassem, D., Nielsen, S. D., Main, K. M., Sjøgren, P., & Kurita, G. P. (2023) · European Journal of Pain · doi:10.1002/ejp.2136 · Cited by 12
Diasso, P. D. K., Frederiksen, B. S., Nielsen, S. D., Main, K. M., Sjøgren, P., & Kurita, G. P. (2021) · European Journal of Pain · doi:10.1002/ejp.1797 · Cited by 12
“, 2011) was low due to limitations in study design, inconsistency of results and imprecision, but was raised one level due to dose– response gradient in some of the outcomes (Lamprecht et al., 2018; Wong et al., 2011) (Table 2).”
BackgroundInfluentialEndocrine Effects of Chronic Opioid Therapy: Implications for Clinical Management
Elliott, J. A., & Fibuch, E. E. (2013) · Pain Management · doi:10.2217/pmt.13.13 · Cited by 10
Kondo, A., Murakami, T., Fujii, T., Tatsumi, M., Ueda-Sakane, Y., Ueda, Y., Yamauchi, I., Ogura, M., Taura, D., & Inagaki, N. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0359 · Cited by 11
“Hypothalamic-pituitary-gonadal axis Serum total or free testosterone: low Wong, 2011 [22], Valverde-Filho, 2015 [23]”
BackgroundSubstance abuse and male sexual dysfunction: what lies beneath?
Mostafa, T., & Alghobary, M. F. (2023) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qead011 · Cited by 12
Rajabizadeh, G., Yazdanpanah, F., & Ramezani, M. A. (2017) · Europe PMC (PubMed Central) · Cited by 4
Special Issues in the Treatment of Women
Gramann, S. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-29863-4_8 · Cited by 3
Gadelha, M. R., Wildemberg, L. E., & Kasuki, L. (2022) · The Pituitary · doi:10.1016/b978-0-323-99899-4.00003-2 · Cited by 2
Opioid-Related Sexual Dysfunction in Men
Nguyen, C. T. Y., La, J., & Yafi, F. A. (2018) · Current Sexual Health Reports · doi:10.1007/s11930-018-0160-7 · Cited by 2
Hypothalamic Regulation of Prolactin Secretion
Wilkinson, M., & Imran, S. A. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108149938.008 · Cited by 3
[Paracentesis in the treatment of ascites in cirrhotic patients].
Otaño, J., Sort, P., & Arroyo, V. (1999) · PubMed · Cited by 2
The Effects of Methadone and Buprenorphine on Testis of Rats
Corsi, K. F. (2012) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.6861
Fertility Assessment in the Male
Polackwich, A. S., & Sabanegh, E. S. (2016) · Current clinical urology · doi:10.1007/978-3-319-27711-0_4
“Chronic opioid use has also be shown to affect male hormones with decreasing free testosterone and increasing prolactin, which may lead to a decrease in sperm production in chronic users [ 70 , 71 ].”
BackgroundThe First Visit: Consult and Workup Before Sperm Banking
Polackwich, A. S., & Garcia-Gil, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-42396-8_12
The complications of tramadol and methadone use to women’s sexual hormone
Saravani, K., Ramezannezhad, P., Delpisheh, M., Mojahed, B. S., Bameri, O., & Aali, H. (2023) · Journal of Shahrekord University of Medical Sciences · doi:10.34172/jsums.2023.752
“Women on opioids had lower free testosterone levels, but this was not associated with sexual dysfunction (43).”
BackgroundOpioide und weibliche Hormonregulation
Christiansen, J. M., & Kiesel, L. (2026) · Gynäkologische Endokrinologie · doi:10.1007/s10304-026-00693-x
Metadata
- Authors
- Wong, D., Gray, D., Simmonds, M., Rashiq, S., Sobolev, I., & Morrish, D. W.
- Affiliations
- University of Alberta (CA)
- Corresponding author
- Morrish, Donald W
- Venue
- Pain Research and Management
- Publisher
- Wiley
- Published
- 2011-01
- Volume
- 16
- Issue
- 5
- Pages
- 311-316
- ISSN
- 1203-6765 (ISSN-L)
- 1918-1523
- PMC
- PMC3206779
- OpenAlex
- W978144381
- Semantic Scholar
- d5c54e00e38695028bf9e4f7814b80cdd3fd5c52
- Cited by
- 32
- References
- 17
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 6 · 2014: 2 · 2013: 1 · 2012: 1
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pain Research and Management (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Alberta Council of Professionals for Sexual Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Keywords
- opioid analgesics, gonadal function, hypogonadism, sexual dysfunction, free testosterone, chronic pain, prolactin, dehydroepiandrosterone sulfate, sex hormone-binding globulin, luteinizing hormone, estradiol, menopause, women with chronic pain, multidisciplinary pain clinic, non-opioid analgesics
- MeSH terms
- Adult, Aged, Aged, 80 and over, Analgesics, Opioid, Female, Humans, Male, Middle Aged, Opioid-Related Disorders, Pituitary Hormones, Prolactin, Prospective Studies, Sex Factors, Statistics as Topic, Sexual Dysfunctions, Psychological, Gonadal Hormones, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.